APA (7th ed.) Citation

Muylaert, C., Van Hemelrijck, L. A., Van der Vreken, A., Heestermans, R., Satilmis, H., Verheye, E., . . . De Bruyne, E. (2025). The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapse. Journal of Experimental & Clinical Cancer Research (17569966), 44(1), 1. https://doi.org/10.1186/s13046-025-03382-y

Chicago Style (17th ed.) Citation

Muylaert, Catharina, et al. "The De Novo DNA Methyltransferase 3B Is a Novel Epigenetic Regulator of MYC in Multiple Myeloma, Representing a Promising Therapeutic Target to Counter Relapse." Journal of Experimental & Clinical Cancer Research (17569966) 44, no. 1 (2025): 1. https://doi.org/10.1186/s13046-025-03382-y.

MLA (9th ed.) Citation

Muylaert, Catharina, et al. "The De Novo DNA Methyltransferase 3B Is a Novel Epigenetic Regulator of MYC in Multiple Myeloma, Representing a Promising Therapeutic Target to Counter Relapse." Journal of Experimental & Clinical Cancer Research (17569966), vol. 44, no. 1, 2025, p. 1, https://doi.org/10.1186/s13046-025-03382-y.